|
2022 Journal Article ctDNA as a biomarker of progression in oesophageal adenocarcinomaBonazzi, V. F., Aoude, L. G., Brosda, S., Lonie, J. M., Patel, K., Bradford, J. J., Koufariotis, L. T., Wood, S., Smithers, B. Mark, Waddell, N. and Barbour, A. P. (2022). ctDNA as a biomarker of progression in oesophageal adenocarcinoma. ESMO Open, 7 (3) 100452, 100452. doi: 10.1016/j.esmoop.2022.100452 |
|
2021 Journal Article Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patientsAoude, Lauren G., Wong, Bernadette, Bonazzi, Vanessa F, Brosda, Sandra, Walters, Shaun B., Koufariotis, Lambros T., Naeini, Marjan M., Pearson, John V, Oey, Harald, Patel, Kalpana, Bradford, Julia J., Bloxham, Conor J, Atkinson, Victoria, Law, Phillip, Strutton, Geoffrey, Bayley, Gerard, Yang, Samuel, Smithers, B. Mark, Waddell, Nicola, Miles, Kenneth and Barbour, Andrew P. (2021). Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patients. Molecular Cancer Research, 19 (6) molcanres.1038.2020, 950-956. doi: 10.1158/1541-7786.mcr-20-1038 |
|
2020 Journal Article Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsAoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola and Barbour, Andrew P. (2020). Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific Reports, 10 (1) 17687, 17687. doi: 10.1038/s41598-020-74956-3 |
|
2015 Journal Article A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinomaWadt, K. A. W., Aoude, L. G., Johansson, P., Solinas, A., Pritchard, A., Crainic, O., Andersen, M. T., Kiilgaard, J. F., Heegaard, S., Sunde, L., Federspiel, B., Madore, J., Thompson, J. F., Mccarthy, S. W., Goodwin, A., Tsao, H., Jonsson, G., Busam, K., Gupta, R., Trent, J. M., Gerdes, A. -M., Brown, K. M., Scolyer, R. A. and Hayward, N. K. (2015). A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clinical Genetics, 88 (3), 267-272. doi: 10.1111/cge.12501 |
|
2015 Journal Article POLE mutations in families predisposed to cutaneous melanomaAoude, Lauren G., Heitzer, Ellen, Johansson, Peter, Gartside, Michael, Wadt, Karin, Pritchard, Antonia L., Palmer, Jane M., Symmons, Judith, Gerdes, Anne-Marie, Montgomery, Grant W., Martin, Nicholas G., Tomlinson, Ian, Kearsey, Stephen and Hayward, Nicholas K. (2015). POLE mutations in families predisposed to cutaneous melanoma. Familial Cancer, 14 (4), 621-628. doi: 10.1007/s10689-015-9826-8 |
|
2014 Journal Article Assessment of PALB2 as a candidate melanoma susceptibility geneAoude, Lauren G., Xu, Mai, Zhao, Zhen Zhen, Kovacs, Michael, Palmer, Jane M., Johansson, Peter, Symmons, Judith, Trent, Jeffrey M., Martin, Nicholas G., Montgomery, Grant W., Brown, Kevin M. and Hayward, Nicholas K. (2014). Assessment of PALB2 as a candidate melanoma susceptibility gene. PLoS One, 9 (6) e100683, e100683.1-e100683.7. doi: 10.1371/journal.pone.0100683 |
|
2013 Journal Article A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancersAoude, Lauren G., Wadt, Karin, Bojesen, Anders, Cruger, Dorthe, Borg, Ake, Trent, Jeffrey M., Brown, Kevin M., Gerdes, Anne-Marie, Jonsson, Goran and Hayward, Nicholas K. (2013). A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PloS One, 8 (8) e72144, e72144. doi: 10.1371/journal.pone.0072144 |
|
2025 Conference Publication Spatial transcriptomics profiling of the tumour microenvironment of esophageal adenocarcinomaBelle, Clemence, Brosda, Sandra, Bonazzi, Vanessa, Kao, Yung-Ching, Brown, Ian, Aoude, Lauren, Stark, Mitchell, Patel, Kalpana, AGITG AGITG DOCTOR Investigators, Atkinson, Victoria and Barbour, Andrew (2025). Spatial transcriptomics profiling of the tumour microenvironment of esophageal adenocarcinoma. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.357 |
|
2025 Conference Publication Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigensLonie, James, Brosda, Sandra, Addala, Venkateswar, Bonazzi, Vanessa, Aoude, Lauren, Zeng, Bijun, Waddell, Nicola, Dolcetti, Riccardo and Barbour, Andrew (2025). Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.314 |
|
2025 Journal Article Utility of germline, somatic and ctDNA testing in adults with cancerDeBortoli, Emily, McGahan, Ella, Yanes, Tatiane, Berkman, Jennifer, Aoude, Lauren G., Smit, Amelia K., Gokoolparsadh, Akira, Hermes, Azure, Newett, Lyndsay, Bourke, Mackenzie, Hanson, Susan, Hughes, Helen, Hofmann, Oliver, Goranitis, Ilias, McWhirter, Rebekah, Milch, Vivienne, Steinberg, Julia and McInerney‐Leo, Aideen (2025). Utility of germline, somatic and ctDNA testing in adults with cancer. Cancer Medicine, 14 (15) e71080, 1-17. doi: 10.1002/cam4.71080 |
|
2025 Conference Publication Identifying genetic drivers of oesophageal adenocarcinomaAoude, Lauren G., Brosda, Sandra, Wong, Ho Yi, Koufariotis, Lambros, Pearson, John V., Waddell, Nicola and Barbour, Andrew P. (2025). Identifying genetic drivers of oesophageal adenocarcinoma. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.354 |
|
2025 Conference Publication Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomicsBelle, Clemence J., Brosda, Sandra, Bonazzi, Vanessa F., Bulteau, Victor, Stuart, Thomas, Xiong, Zherui, Lambie, Duncan, Johansson, Peter A., Aoude, Lauren G., Patel, Kalpana, Stehbens, Samantha J., Stark, Mitchell S., Haass, Nikolas K., Xu, Wen, Pinkham, Mark B., Foote, Matthew C., Olson, Sarah, Atkinson, Victoria, Kulasinghe, Arutha, Nguyen, Quan H. and Barbour, Andrew (2025). Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomics. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-5076 |
|
2024 Journal Article Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapyBrosda, Sandra, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Lonie, James M., Belle, Clemence J., Newell, Felicity, Koufariotis, Lambros T., Addala, Venkateswar, Naeini, Marjan M., Simes, John, Walpole, Euan T., Mai, Gang T., Watson, David I., Karapetis, Chris S., Gebski, Val, Barnes, Elizabeth H., Oostendorp, Martijn, Wilson, Kate, Ackland, Stephen P., Shannon, Jenny, Marx, Gavin, Burge, Matthew, Finch, Robert, Thomas, Janine, Varma, Suresh, Nott, Louise, Pearson, John V., Krause, Lutz ... Barbour, Andrew P. (2024). Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy. Genome Medicine, 16 (1) 90, 90. doi: 10.1186/s13073-024-01362-z |
|
2024 Conference Publication Unsupervised clustering of PET/CT imaging features in stage III/IV melanomaVashistha, Rajat, Moradi, Hamed, Brosda, Sandra, Aoude, Lauren, Vegh, Viktor and Barbour, Andrew (2024). Unsupervised clustering of PET/CT imaging features in stage III/IV melanoma. Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Toronto, ON, Canada, 8-11 June 2024. Reston, VA, United States: Society of Nuclear Medicine. |
|
2024 Journal Article POT1 and multiple primary melanomas: the dermatological phenotypeMaas, Ellie J., DeBortoli, Emily, Nathan, Vaishnavi, Freeman, Ned P., Mothershaw, Adam, Smit, Darren J., Betz-Stablein, Brigid, Aoude, Lauren G., Stark, Mitchell S., Sturm, Richard A., Soyer, H. Peter and McInerney-Leo, Aideen M. (2024). POT1 and multiple primary melanomas: the dermatological phenotype. Journal of Medical Genetics, 61 (9) jmg-2023-109637, 1-4. doi: 10.1136/jmg-2023-109637 |
|
2024 Journal Article The role of artificial intelligence and convolutional neural networks in the management of melanoma: a clinical, pathological, and radiological perspectiveYee, Joshua, Rosendahl, Cliff and Aoude, Lauren G. (2024). The role of artificial intelligence and convolutional neural networks in the management of melanoma: a clinical, pathological, and radiological perspective. Melanoma Research, 34 (2), 96-104. doi: 10.1097/cmr.0000000000000951 |
|
2023 Journal Article The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobankLonie, James M., Brosda, Sandra, Bonazzi, Vanessa F., Aoude, Lauren G., Patel, Kalpana, Brown, Ian, Sharma, Sowmya, Lampe, Guy, Addala, Venkateswar, Koufariotis, Lambros T., Wood, Scott, Waddell, Nicola, Dolcetti, Riccardo and Barbour, Andrew P. (2023). The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank. Frontiers in Immunology, 14 1220129, 1-15. doi: 10.3389/fimmu.2023.1220129 |
|
2023 Journal Article ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patientsAoude, Lauren G., Brosda, Sandra, Ng, Jessica, Lonie, James M., Belle, Clemence J., Patel, Kalpana, Koufariotis, Lambros T., Wood, Scott, Atkinson, Victoria, Smithers, B. Mark, Pearson, John V., Waddell, Nicola, Barbour, Andrew P. and Bonazzi, Vanessa F. (2023). ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients. Journal of Molecular Diagnostics, 25 (10), 771-781. doi: 10.1016/j.jmoldx.2023.06.014 |
|
2023 Journal Article GOLM1: expanding our understanding of melanoma susceptibilityMaas, Ellie J., Wallingford, Courtney K., DeBortoli, Emily, Smit, Darren J., Betz-Stablein, Brigid, Aoude, Lauren G., Stark, Mitchell S., Sturm, Richard A., Soyer, H. Peter and McInerney-Leo, Aideen M. (2023). GOLM1: expanding our understanding of melanoma susceptibility. Journal of Medical Genetics, 60 (9) jmg-2023-109348, 1-3. doi: 10.1136/jmg-2023-109348 |
|
2023 Journal Article C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patientsBonazzi, Vanessa F., Aoude, Lauren G., Brosda, Sandra, Bradford, Julia J., Lonie, James M., Loffler, Kelly A., Gartside, Michael G., Patel, Kalpana, Mukhopadhyay, Pamela, Keane, Colm, Gebski, Val, Kench, James G., Goldstein, David, Waddell, Nicola, Barbour, Andrew P. and the Australasian Gastro‐Intestinal Trials Group (AGITG) GAP investigators (2023). C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology, 21 (1), 77-86. doi: 10.1111/ajco.13993 |
